Apparatuses and Methods for Treating Ophthalmic Diseases and Disorders
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 2 of these applications claim priority to application 15/051,477, filed Feb 23, 2016. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,590,265 | Apparatuses and Methods for Treating Ophthalmic Diseases and Disorders In force · Medium confidence | Biotissue Holdings Inc. | In force | Medium confidence | ||
| US 12,508,349 | Apparatuses and Methods for Treating Ophthalmic Diseases and Disorders In force · Medium confidence | Biotissue Holdings Inc. | In force | Medium confidence | ||
| Application 19/400,523 | Apparatuses and Methods for Treating Ophthalmic Diseases and Disorders Pending Not granted | Biotissue Holdings Inc. | Pending | Not granted |
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Biotissue Holdings Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.